Acquired Hemophilia A Treated with Recombinant Porcine Factor VIII: Case Report and Literature Review on Its Efficacy

Acquired Hemophilia A Treated with Recombinant Porcine Factor VIII: Case Report and Literature Review on Its Efficacy

Acquired hemophilia A (AHA) is a bleeding disorder due to the presence of neutralizing autoantibodies named inhibitors in patients with a previously normal hemostasis. Recent international recommendations suggest the use of bypassing agents or substitutive therapy as the first-line treatment, usuall...

Full description

Bibliographic Details
Main Authors: Matteo Borro, Riccardo Tassara, Luca Paris, Nathan Artom, Marcello Brignone, Lara Rebella, Rodolfo Tassara
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Hematology Reports
Subjects:
Acquired Hemophilia A
susoctocog-alfa
prolonged activated partial thromboplastin time
Online Access:https://www.mdpi.com/2038-8330/15/1/3

Internet

https://www.mdpi.com/2038-8330/15/1/3

Similar Items